For medical device companies preparing FDA 510(k) documentation, predicate strategy, substantial equivalence, or US market entry.
Built for companies with a defined medical device, documentation in progress, or a clear US market entry goal.
Trusted by regulated market teams














This service is designed for teams preparing a real medical device for FDA review, not for early ideas, courses, or general research.
If route, predicate, evidence or eSTAR structure are still uncertain, Sobel can help organize the next step.

A weak predicate strategy, unclear documentation, or inconsistent claims can create FDA questions, rework, and delays.
Sobel helps organize your regulatory path, documentation gaps, and submission logic before you move forward.

Your deliverables are designed to make the 510(k) logic easier to review, organize and defend internally.

Clarify the 510(k) pathway, device positioning, intended use, and regulatory route.
Review predicate logic, substantial equivalence rationale, claims, and labeling consistency.

Identify missing, weak, or inconsistent documentation before FDA questions arise.

Receive clear next steps to complete, correct, or strengthen your 510(k) preparation.

A clear workflow helps your team reduce uncertainty before the submission is assembled.
You share your device information
Send available documentation, intended use, claims, labeling, testing, and product details
We assess your 510(k) position:
We review your pathway, predicate strategy, and substantial equivalence logic
We identify the main risks:
We flag documentation, evidence, labeling, or testing gaps that may create FDA questions.
We organize the next steps:
You receive a structured view of what needs to be corrected, completed, or clarified.
You move forward with confidence:
Your team receives the documentation, notes and handover needed to proceed.
Specialized support for companies preparing 510(k) documentation, FDA strategy, and US market entry.
We help identify regulatory and documentation gaps before they become costly delays.
We guide foreign manufacturers preparing to enter the US medical device market.
Our review connects intended use, predicate logic, evidence, labeling, and submission readiness.
Your team receives practical direction before moving forward with FDA review.

Tell us about your device, current documentation, and FDA market entry goal. Sobel will review how we can support your next step.
This support is best for medical device companies with a defined product, documentation in progress, and a plan to enter or operate in the US market.
No. Sobel can support companies before submission by reviewing the pathway, documentation gaps, predicate strategy, and readiness risks.
Yes. We can review your device information, intended use, and regulatory position to help clarify the most appropriate next steps.
No. This is professional regulatory support for companies preparing a real medical device for FDA review.
Yes. Sobel supports international companies with FDA regulatory strategy, documentation review, registration, listing, and market entry planning.
Ideally, you should have a defined product, intended use, target market, manufacturer information, and at least some technical or regulatory documentation.
To provide the best experiences, we use technologies such as cookies to store and/or access device information. Consenting to these technologies allows us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent may negatively affect certain features and functions.